Gilead Sciences, the maker of a twice-a-year anti-HIV injection, has approached South Africa’s medicine regulator to discuss ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

A Chinese research team has isolated an antibody from alpacas that can effectively inhibit HIV, providing a promising avenue ...

Statins have had an evolving role in the management of cardiovascular risk in people living with HIV, explained Michelle ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...

Antiviral Drugs MarketThe antiviral drugs market is anticipated to experience significant growth, flourishing at an average ...

Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

But in terms of HIV preventions, there is already another groundbreaking drug called lenacapavir. The anti-HIV compound is already in use, but getting the drug to those who need it most could ...

Historically, as mentioned, PrEP has been used to treat cisgender gay men, especially in light of the HIV crisis of the 1980s ...